CLINICAL_TRIALS
trial_result
· 2016-06-02
Clinical Trial Update: Tocilizumab for the Treatment of Behcet's Syndrome [Phase 2]
Summary
A Phase 2 trial evaluating tocilizumab for Behçet's disease was terminated early. Results were posted on 2016-06-02.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Behcet Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2016-06-02